Search
for
Sort by
Research 31–60 of 224
- pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
- Prevention of erlotinib-induced folliculitis with doxycycline
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Clinical efficacy and safety of Kanglaite injection, adjuvant cemcitabine and cisplatin chemotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis
- Anticancer activity of cepharanthine on non-small cell lung cancer cells
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- The clinical observation of first-line docetaxel and carboplatin treatment for elderly patients with non-selective non-small-cell lung cancer
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Characters of KRT80 and its roles in neoplasms diseases
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- Transforming growth factor-β in stem cells and tissue homeostasis
- Tracing the cellular origin of cancer
- Anthracycline analogs The past, present, and future
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Targeting the Wnt pathways for therapies
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- LncRNA PlncRNA‑1 regulates proliferation and differentiation of hair follicle stem cells through TGF‑β1‑mediated Wnt/β‑catenin signal pathway